New Apoptosis Inducers Containing Anti-inflammatory Drugs and Pnictogen Derivatives: A New Strategy in the Development of Mitochondrial Targeting Chemotherapeutics-Reference-Cited by-同舟云学术

New Apoptosis Inducers Containing Anti-inflammatory Drugs and Pnictogen Derivatives: A New Strategy in the Development of Mitochondrial Targeting Chemotherapeutics

Published:2023-02-07 Issue:6 Volume:66 Page:4131-4149
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Banti Christina N.¹,Papatriantafyllopoulou Constantina²^ORCID,Papachristodoulou Christina³,Hatzidimitriou Antonios G.⁴,Hadjikakou Sotiris K.¹⁵^ORCID

Affiliation:

1. Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece

2. School of Chemistry, College of Science and Engineering, National University of Ireland, H91 TK33 Galway, Ireland

3. Department of Physics, University of Ioannina, 45110 Ioannina, Greece

4. Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece

5. Institute of Materials Science and Computing, University Research Center of Ioannina (URCI) Ioannina, 45110 Ioannina, Greece

Funder

Novartis

State Scholarships Foundation

European Commission

European Social Fund

Greek national funds

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c02126

Reference61 articles.

1. D., Guzman-Villanueva; V., Weissig, Mitochondria-Targeted Agents: Mitochondriotropics, Mitochondriotoxics, and Mitocans in Pharmacology of Mitochondria, Vol. 240 (Eds H., Singh; S.S., Sheu) Cham, Switzerland: Springer International Publishing; 2016, pp. 424–438.

2. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications

3. Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism

4. Mixed ligand–silver(i) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis

5. Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria;European Journal of Medicinal Chemistry;2024-11

2. Anti‐Breast Cancer Stem Cell Properties of Silver(I)‐Non‐Steroidal Anti‐Inflammatory Drug Complexes;European Journal of Inorganic Chemistry;2024-07-12

3. Silver(I) Complexes with Mefenamic Acid and Nitrogen Heterocyclic Ligands: Synthesis, Characterization, and Biological Evaluation;Inorganic Chemistry;2024-06-24

4. Controlled dual activity of an organometallic antibiotic through micelle formulation;Journal of Organometallic Chemistry;2024-05

5. Silver ciprofloxacin (CIPAG): a multitargeted metallodrug in the development of breast cancer therapy;JBIC Journal of Biological Inorganic Chemistry;2024-04-06